Gastrointestinal Bleeding in a 6-Year-Old Female

Sangkaew S Ming D Boonyasiri A , et al Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(7):1014-1026. doi:10.1016/S1473-3099(20)30601-0.

Guzman MG Gubler DJ Izquierdo A Martinez E Halstead SB. Dengue infection. Nat Rev Dis Primers. 2016;2:16055. doi:10.1038/nrdp.2016.55.

Sachdev A Pathak D Gupta N , et al Early predictors of mortality in children with severe dengue fever: a prospective study. Pediatr Infect Dis J. 2021;40(9):797-801. doi:10.1097/INF.0000000000003179.

Gulati S Maheshwari A. Atypical manifestations of dengue. Trop Med Int Health. 2007;12(9):1087-1095. doi:10.1111/j.1365-3156.2007.01891.x.

Kularatne SA Dalugama C. Dengue infection: global importance, immunopathology and management. Clin Med (Lond). 2022;22(1):9-13. doi:10.7861/clinmed.2021-0791.

Dirección General de Epidemiología. Panorama Epidemiológico de Dengue 2023. Semana Epidemiológica 43, 2023. Accessed November 1, 2023. https://www.gob.mx/salud/documentos/panorama-epidemiologico-de-dengue-2023.

Laureano-Rosario AE Garcia-Rejon JE Gomez-Carro S Farfan-Ale JA Muller-Karger FE. Modelling dengue fever risk in the State of Yucatan, Mexico using regional-scale satellite-derived sea surface temperature. Acta Trop. 2017;172:50-57. doi:10.1016/j.actatropica.2017.04.017.

Hadinegoro SR Arredondo-García JL Capeding MR , et al Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med. 2015;373(13):1195-1206. doi:10.1056/NEJMoa1506223.

Pan American Health Organization; World Health Organization. Regional guidelines for dengue vaccine safety surveillance, QDENGA—TAK-003. 2025. https://iris.paho.org/handle/10665.2/67980.

Tricou V Yu D Reynales H , et al Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2024;12(2):e257-e270. doi:10.1016/S2214-109X(23)00522-3.

Pothapregada S Kamalakannan B Thulasingham M Sampath S. Clinically profiling pediatric patients with dengue. J Glob Infect Dis. 2016;8(3):115-120. doi:10.4103/0974-777X.188596.

Pan American Health Organization. Guidelines for the Clinical Diagnosis and Treatment of Dengue, Chikungunya, and Zika. Washington, DC: Pan American Health Organization; 2022. https://iris.paho.org/handle/10665.2/55867.

Zhang F Kramer CV. Corticosteroids for dengue infection. Cochrane Database Syst Rev. 2014;2014(7):CD003488. doi:10.1002/14651858.CD003488.pub3.

Saddique J Ghaffar M Shabbir MR , et al Platelet transfusion and tranexamic acid in the treatment of bleeding in dengue fever. J Pharm Res Int. 2022;34(39B):58-65. doi:10.9734/JPRI/2022/v34i39B36248.

Kaur A Bhargava S Dhooria GS , et al Albumin infusion in children with fluid refractory severe dengue: a comparative study. Indian Pediatr. 2025;62(2):102-108. doi:10.1007/s13312-025-3372-8.

Thadchanamoorthy V Dayasiri K. Expanded dengue syndrome presenting with acute liver failure, acute kidney injury, pancreatic involvement, coagulopathy, and multiple intracranial hemorrhages in a young child: a case report. J Med Case Rep. 2022;16(1):123. doi:10.1186/s13256-022-03348-0.

Tabah A Buetti N Staiquly Q , et al Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med. 2023;49(2):178-190. doi:10.1007/s00134-022-06944-2.